相关实验视频
Updated: Jul 18, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
基因疗法:治疗性基因导致淋巴瘤
Niels-Bjarne Woods1, Virginie Bottero, Manfred Schmidt
1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037, USA.
使用IL2RG基因治疗X关联严重联合免疫缺陷 (X-SCID) 的基因治疗可能会带来风险. 研究表明,治疗基因本身可以在小鼠模型中促进T细胞淋巴瘤的发展.
科学领域:
- 免疫学 免疫学 免疫学
- 基因治疗 基因治疗
- 在瘤学瘤学.
背景情况:
- 使用造血干细胞的基因疗法已经显示出治疗X-SCID (X-SCID) 的承诺.
- 然而,最近的试验已经在治疗患者中发现T细胞白血病的发展,这促使重新评估这种方法的安全性.
研究的目的:
- 研究IL2RG基因的潜在致癌作用,IL2RG基因是X-SCID基因治疗中使用的校正治疗基因.
- 在临床前模型中评估与IL2RG基因治疗相关的T细胞淋巴瘤发展风险.
主要方法:
- 一个小鼠模型被用来模拟X-SCID的基因治疗.
- 该研究的重点是IL2RG基因作为治疗剂的影响.
主要成果:
- 发现IL2RG基因有助于T细胞淋巴瘤的发展,在大量 (三分之一) 的受治疗动物中.
- 这一发现挑战了之前的假设,即IL2RG具有最小的致癌性.
结论:
- 使用IL2RG基因进行X-SCID的基因治疗可能会带来诱导T细胞淋巴瘤的固有风险.
- 这些发现需要仔细重新评估X-SCID基因疗法试验的安全协议和风险效益分析.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
相关概念视频
Gene Therapy
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy